临床儿科杂志 ›› 2021, Vol. 39 ›› Issue (7): 491-.doi: 10.3969/j.issn.1000-3606.2021.07.003

• 消化系统疾病专栏 • 上一篇    下一篇

进行性家族性肝内胆汁淤积症2 例临床及遗传学分析

何佳倩 1, 孙长宇 1, 乔芳芳 1, 郑利民 2   

  1. 1 .郑州大学第一附属医院感染性疾病科(河南郑州 450000); 2.中山大学生命科学学院 (广东广州 510060)
  • 发布日期:2021-07-01
  • 通讯作者: 孙长宇 电子信箱:changyu8188@163com
  • 基金资助:
    国家科技重大专项项目(No. 2018 ZX 10302 -205)

Clinical and genetic analysis of two cases with progressive familial intrahepatic cholestasis

HE Jiaqian1 , SUN Changyu1 , QIAO Fangfang1 , ZHENG Limin2   

  1. 1 . Department of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000 , Henan, China; 2 . School of Life Science, Sun Yat-Sen University, Guangzhou 510060 , Guangdong, China
  • Published:2021-07-01

摘要: 目的 探讨进行性家族性肝内胆汁淤积症(PFIC)的临床及遗传学特征。方法 回顾分析2例PFIC患儿的 临床资料和基因检测结果。结果 例1,女性,15岁,临床表现以黄疸、皮肤瘙痒、白色黏稠便为主,伴脾大;例2,男性, 3岁6月龄,表现为黄疸、皮肤瘙痒。全外显子测序发现,例1的ATP 8 B 1基因存在c. 2652 G>C和c. 1573 C>T复合杂合变 异,其中c. 2652 G>C变异遗传自父亲,c. 1573 C>T变异遗传自母亲,c. 2652 G>C是既往未见报道的新变异位点。例2的 ABCB 11基因存在c.2606A>C纯合错义变异,来源于父母。结论 基因检测有助于PFIC的明确诊断及治疗。此研究丰富 了ATP 8 B 1致病变异谱。

关键词: 进行性家族性肝内胆汁淤积症; ATP 8 B 1基因; ABCB11基因; 黄疸; 基因分析

Abstract: Objective To explore the clinical and genetic characteristics of progressive familial intrahepatic cholestasis (PFIC). Method Clinical data and genetic results of the patients were retrospectively analyzed. Peripheral blood samples were collected, and genomic DNA was extracted, whole exome sequencing (WES) was used to identify the genetic cause. Results Case 1, a 15 years old female, presented with jaundice, skin itching, white sticky stools, accompanied by splenomegaly; case 2 , a 3 years and 6 months old male, manifested as jaundice and skin itching. WES analysis revealed compound heterozygous mutations of c.2652 G>C from the father and c.1573 C>T from the mother in the ATP 8 B 1 gene of patient 1 . c.2652 G>C is a novel mutation which has not been reported before. In case 2 , WES identified a homozygous missense mutation of c.2606 A>C in the ABCB 11 gene, which were inherited from his parents. Conclusion The diagnosis of progressive familial intrahepatic cholestasis needs to combine clinical manifestations, histopathological findings and genetic testing, and to exclude other related diseases that lead to cholestasis; genetic testing is helpful for confirming the diagnosis and treatment of PFIC. The mutations reported in this paper enriched the pathogenic mutation spectrum of ATP 8 B 1.

Key words: progressive familial intrahepatic cholestasis; ATP 8 B 1 gene; ABCB11 gene; jaundice; genetic analysis